59,539
Views
111
CrossRef citations to date
0
Altmetric
Editorial

The antiviral properties of vitamin C

, &
Pages 99-101 | Received 14 Sep 2019, Accepted 16 Dec 2019, Published online: 23 Dec 2019

References

  • Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151:1229–1238.
  • Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;1:CD000980.
  • Pauling L. The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad Sci U S A. 1971;68:2678–2681.
  • Pauling L, Rath M. An orthomolecular theory of human health and disease. J Orthomol Med. 1991;6:135–138.
  • Oudemans-van Straaten HM, Spoelstra-de Man AM`, de Waard MC. Vitamin C revisited. Crit Care. 2014;18:460.
  • McNamara R, Deane AM, Anstey J, et al. Understanding the rationale for parenteral ascorbate (vitamin C) during an acute inflammatory reaction: a biochemical perspective. Crit Care Resusc. 2018;20:174–179.
  • While LA, Freeman CY, Forrester BD, et al. In vitro effect of ascorbic acid on infectivity of herpesviruses and paramyxoviruses. J Clin Microbiol. 1986;24:527–531.
  • Klein M. The mechanism of the virucidal action of ascorbic acid. Science. 1945;101:587–589.
  • Marik PE. Hydrocortisone, ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid. Nutrients. 2018;10:1762.
  • Avci P, Freire F, Banvolgi A, et al. Sodium ascorbate kills Candida albicans in vitro via iron-catalyzed fenton reaction: importance of oxygenation and metabolism. Future Microbiol. 2016;11:1535–1547.
  • Uesato S, Kitagawa Y, Kaijima T, et al. Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight- or branched-acyl chain on epstein-barr virus activation. Cancer Lett. 2001;166:143–146.
  • Cinatl J, Cinatl J, Weber B, et al. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral Res. 1995;27:405–418.
  • Carr AC. Vitamin C and Immune Function. Nutrients. 2017;9:1211.
  • May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013;19:2068–2083.
  • Leibovitz B, Siegel BV. Ascorbic acid and the immune response. Adv Exp Med Biol. 1981;135:1–25.
  • Dey S, Bishayi B. Killing of S.aureus in murine peritoneal macrophages by ascorbic acid along with antibiotics chloramphenicol or ofloxacin: correlation with inflammation. Microb Pathog. 2018;115:239–250.
  • Kim Y, Kim H, Bae S, et al. Vitamin C is an essential factor on the anti-viral immune response through the production of interferon-alpha/beta at the initial stage of influenza A virus (H3N2) infection. Immune Netw. 2013;13:70–74.
  • Li W, Maeda N, Beck MA. Vitamin C deficiency increases the lung pathology of influenza virus-infected gulo-/- mice. J Nutr. 2006;136:2611–2616.
  • Cai Y, Li YF, Tang LP, et al. A new mechanism of vitamin C effects on A/FM/1/47(H1N1) virus-induced pneumonia in restraint-stressed mice. Biomed Res Int. 2015;2015:675149.
  • Valero N, Mosquera J, Alcocer S, et al. Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental venezuelan equine encephalitis. Brain Res. 2015;1622:368–376.
  • Lallement A. Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report. J Med Case Rep. 2015;9:1.
  • Moens B, Decanine D, Menezes SM, et al. Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-alpha in HTLV-1-associated myelopathy. PLoS Negl Trop Dis. 2012;6:e1729.
  • Kataoka A, Imai H, Inayoshi S, et al. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy. J Neurol Neurosurg Psy. 1993;56:1213–1216.
  • Harakeh S. NF-kappa B-independent suppression of HIV expression by ascorbic acid. AIDS Res Hum Retroviruses. 1997;13:235–239.
  • Rawal BD, Bartolini F, Vyas GN. In vitro inactivation of human immunodeficiency virus by ascorbic acid. Biologicals. 1995;23:75–81.
  • Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci U S A. 1990;87:7245–7249.
  • Banic S. Prevention of rabies by vitamin C. Nature. 1975;258:153–154.
  • Hosakote YM, Jantzi PD, Esham DL, et al. Viral-mediated in hibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2011;183:1550–1560.
  • Castro SM, Guerrero-Plata A, Suarez-Real G, et al. Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am J Respir Crit Care Med. 2006;174:1361–1369.
  • Marik PE. Vitamin C for the treatment of sepsis: the scientific rationale. Pharmacol Therapeut. 2018;189:63–70.
  • Chen JY, Chang CY, Feng PH, et al. Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain. 2009;25:562–569.
  • Kim MS, Kim DJ, Na CH, et al. A study of intravenous administration of vitamin C in the treatment of acute herpetic pain and postherpetic neuralgia. Ann Dermatol. 2016;28:677–683.
  • Kim GN, Yoo WS, Park MH, et al. Clinical features of herpes simplex keratitis in a Korean tertiary referral center: efficacy of oral antiviral and ascorbic acid on Recurrence. Korean J Opthal. 2018;32:353–360.
  • Lansbury LE. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated cochrane systematic review and meta-analysis. Crit Care Med. 2019;1. ePub. DOI:10.1097/CCM.0000000000004093.
  • Rodrigo C. Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. J Infect Dis. 2015;212:183–194.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.